Skip to main content

Sickle Cell Disease in Social Security Disability Evaluations

Recently completed

The U.S. Social Security Administration has requested the National Academies of Sciences, Engineering, and Medicine establish an ad hoc committee to conduct a study to review the latest published research and science and produce a report addressing best practices and community experiences in the management and treatment of sickle cell disease, including hospitalization, parenteral narcotic pain medication, and traditional and alternative therapies and home remedies, their prevalence, efficacy, and side-effects, as well as recent changes or challenges in the provision of such care.

Featured publication

Sickle cell disease (SCD), a group of inherited blood disorders affecting approximately 100,000 people in the U.S., is a life-long condition that impacts every organ system in the body. Symptoms and complications vary from mild to severe and can include acute and chronic pain, acute chest syndrome,...

View details

Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.